The corrected donor age for hepatitis C virus–infected liver transplant recipients

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|21|8|1022-1030

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.8, 2015-08, pp. : 1022-1030

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 823-830

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utilization of hepatitis C virus RNA–positive donor liver for transplant to hepatitis C virus RNA–negative recipient

By  

LIVER TRANSPLANTATION, Vol. 24, Iss. 1, 2018-01 ,pp. : 140-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus–coinfected liver transplant recipients

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 2, 2015-02 ,pp. : 272-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcomes of living donor liver transplantation for hepatitis C virus‐positive recipients in Japan: results of a nationwide survey

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 8, 2014-08 ,pp. : 767-774

John Wiley & Sons Inc

Access to resources Recommend Favorite

A retrospective 15‐year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 4, 2015-02 ,pp. : 379-392

John Wiley & Sons Inc

Access to resources Recommend Favorite